Despite previous reports in other cancer types of hERV type I interferon enhancement via toll-like receptor 3 (TLR3) activation, we saw negligible expression of TLR3 within our scRNA-seq or bulk RNA sequencing datasets (Supplementary Fig. S6B; ref. 41). The gene discussed is TLR3; the disease is cancer.